Bronchoconstriction following nebulised colistin in cystic fibrosis

Archives of Disease in Childhood

Volumn 84, Issue 5, 2001, Pages 432-433

  Cunningham, S ^a   Prasad, A ^a   Collyer, L ^b   Carr, S ^b   Balfour Lynn, I ^c   Wallis, C ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bronchoconstriction; Colistin; Cystic fibrosis

Indexed keywords

COLISTIN;

ADOLESCENT; ARTICLE; BRONCHOSPASM; CHILD; CYSTIC FIBROSIS; DRUG EFFECT; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT INDICATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTI-BACTERIAL AGENTS; BRONCHOCONSTRICTION; CHILD; CHILD, PRESCHOOL; COLISTIN; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMANS; PROSPECTIVE STUDIES;

EID: 0035022770     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.84.5.432     Document Type: Article

References (6)

1. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: A meta analysis of benefits and risks
2. Effect of tonicity of nebulised colistin on chest tightness in adults with cystic fibrosis
3. The functional development of the respiratory system from the period of gestation to adulthood
4. Bronchial response to nebulised antibiotics in children with cystic fibrosis
5. Inhaled tobramycin and bronchial hyperactivity in cystic fibrosis
6. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis